Early research (Phase 1)UnknownNCT05740917What this trial is testingTo Evaluate the Phase I Clinical Study of XZB-0004 in Patients With AML and MDSWho this might be right forAMLMDS Xuanzhu Biopharmaceutical Co., Ltd. 82
Not applicableLooking for participantsNCT07250217What this trial is testingDetermination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly PatientsWho this might be right forAcute Myeloblastic Leukemia Groupe Hospitalier de la Region de Mulhouse et Sud Alsace 30
Testing effectiveness (Phase 2)UnknownNCT05951855What this trial is testingStudy of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) PatientsWho this might be right forAcute Myeloid Leukemia (Relapsed/Refractory) The First Affiliated Hospital of Soochow University 42
Not applicableStudy completedNCT04679285What this trial is testingMinimal Residual Disease Evaluation on Cryopreserved Ovarian Fragments in Younger Patients Treated for Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia University Hospital, Lille 9
Not applicableUnknownNCT02345915What this trial is testingEvaluation of Adverse Long-term Effects in Young Adult Survivors of Acute LeukemiaWho this might be right forLeukemia, Myeloid, AcuteAcute Lymphoid Leukemia Institut Paoli-Calmettes 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT02790515What this trial is testingProvision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior TransplantationWho this might be right forAcute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myeloid Sarcoma+4 more St. Jude Children's Research Hospital 170
Testing effectiveness (Phase 2)Active Not RecruitingNCT04023526What this trial is testingCusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive ChemotherapyWho this might be right forLeukemia, Myeloid, Acute OncoVerity, Inc. 103
Not applicableStudy completedNCT01805843What this trial is testingPulmonary Vasculopathy Under Second-line Therapy of Chronic Myeloid LeukemiaWho this might be right forChronic Myeloid Leukemia Medical University of Graz 16
Large-scale testing (Phase 3)Study completedNCT00002517What this trial is testingCombination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes European Organisation for Research and Treatment of Cancer - EORTC
Early research (Phase 1)Ended earlyNCT00100152What this trial is testingA Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013)Who this might be right forLeukemia, Lymphoblastic, Acute, T-cellMyelogenous LeukemiaChronic Lymphocytic Leukemia+1 more Merck Sharp & Dohme LLC 50
Not applicableStudy completedNCT05456048What this trial is testingInfluence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AMLWho this might be right forRelapsed Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaGene Abnormality+1 more Nanfang Hospital, Southern Medical University 231
Large-scale testing (Phase 3)Study completedNCT03959241What this trial is testingTAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)Who this might be right forAcute LeukemiaChronic Myelogenous Leukemia (CML)Myelodysplasia+1 more Medical College of Wisconsin 431
Large-scale testing (Phase 3)UnknownNCT03942094What this trial is testingNilotinib for First-line Newly Diagnosed CML-CP PatientsWho this might be right forChronic Myeloid Leukemia, Chronic PhaseNilotinib Shenzhen Second People's Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00056966What this trial is testingConditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological DiseasesWho this might be right forHematologic Malignancy Baylor College of Medicine 24
Testing effectiveness (Phase 2)Ended earlyNCT02152956What this trial is testingFlotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)Who this might be right forAML MacroGenics 244
Testing effectiveness (Phase 2)Study completedNCT00003875What this trial is testingBusulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid LeukemiaWho this might be right forAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+5 more Fred Hutchinson Cancer Center 30
Early research (Phase 1)Looking for participantsNCT04260022What this trial is testingStudy of HQP1351 in Subjects With Refractory CML and Ph+ ALLWho this might be right forLeukemia, Myeloid, ChronicMyeloid LeukemiaChronic Myeloid Leukemia+2 more Ascentage Pharma Group Inc. 242
Early research (Phase 1)Study completedNCT01475370What this trial is testingStudy of OCV-501 in Patients With Acute Myeloid Leukemia (AML) (Extension From Study 311-10-001)Who this might be right forAcute Myeloid Leukemia Otsuka Pharmaceutical Co., Ltd. 18
Early research (Phase 1)Study completedNCT00136422What this trial is testingStudy of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous LeukemiaWho this might be right forAcute Myelogenous LeukemiaMyelodysplasia Dana-Farber Cancer Institute 30
Testing effectiveness (Phase 2)Study completedNCT02763475What this trial is testingNK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/AdolescentsWho this might be right forAcute Myeloid LeukemiaLeukemiaMyeloid Leukemia Instituto de Investigación Hospital Universitario La Paz 7